MedCap AB (publ)
STO:MCAP

Watchlist Manager
MedCap AB (publ) Logo
MedCap AB (publ)
STO:MCAP
Watchlist
Price: 591 SEK -1.17% Market Closed
Market Cap: 8.8B SEK
Have any thoughts about
MedCap AB (publ)?
Write Note

Intrinsic Value

The intrinsic value of one MCAP stock under the Base Case scenario is 486.21 SEK. Compared to the current market price of 591 SEK, MedCap AB (publ) is Overvalued by 18%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MCAP Intrinsic Value
486.21 SEK
Overvaluation 18%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
MedCap AB (publ)

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
MCAP
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MCAP cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about MCAP?
Bearish
Neutral
Bullish

Fundamental Analysis

591 SEK
-1.17%
-1.17%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

MedCap AB (publ)
SE
Life Sciences Tools & Services
Market Cap
8.8B SEK
IPO
Jul 4, 2006
Employees
375
Sweden
Market Cap
8.8B SEK
Industry
Life Sciences Tools & Services
IPO
Jul 4, 2006
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about MedCap AB (publ)

Provide an overview of the primary business activities
of MedCap AB (publ).

What unique competitive advantages
does MedCap AB (publ) hold over its rivals?

What risks and challenges
does MedCap AB (publ) face in the near future?

Has there been any significant insider trading activity
in MedCap AB (publ) recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for MedCap AB (publ).

Provide P/S
for MedCap AB (publ).

Provide P/E
for MedCap AB (publ).

Provide P/OCF
for MedCap AB (publ).

Provide P/FCFE
for MedCap AB (publ).

Provide P/B
for MedCap AB (publ).

Provide EV/S
for MedCap AB (publ).

Provide EV/GP
for MedCap AB (publ).

Provide EV/EBITDA
for MedCap AB (publ).

Provide EV/EBIT
for MedCap AB (publ).

Provide EV/OCF
for MedCap AB (publ).

Provide EV/FCFF
for MedCap AB (publ).

Provide EV/IC
for MedCap AB (publ).

Show me price targets
for MedCap AB (publ) made by professional analysts.

What are the Revenue projections
for MedCap AB (publ)?

How accurate were the past Revenue estimates
for MedCap AB (publ)?

What are the Net Income projections
for MedCap AB (publ)?

How accurate were the past Net Income estimates
for MedCap AB (publ)?

What are the EPS projections
for MedCap AB (publ)?

How accurate were the past EPS estimates
for MedCap AB (publ)?

What are the EBIT projections
for MedCap AB (publ)?

How accurate were the past EBIT estimates
for MedCap AB (publ)?

Compare the revenue forecasts
for MedCap AB (publ) with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of MedCap AB (publ) and its key competitors using the latest financial data.

Compare historical revenue growth rates
of MedCap AB (publ) against its competitors.

Analyze the profit margins
(gross, operating, and net) of MedCap AB (publ) compared to its peers.

Compare the P/E ratios
of MedCap AB (publ) against its peers.

Discuss the investment returns and shareholder value creation
comparing MedCap AB (publ) with its peers.

Analyze the financial leverage
of MedCap AB (publ) compared to its main competitors.

Show all profitability ratios
for MedCap AB (publ).

Provide ROE
for MedCap AB (publ).

Provide ROA
for MedCap AB (publ).

Provide ROIC
for MedCap AB (publ).

Provide ROCE
for MedCap AB (publ).

Provide Gross Margin
for MedCap AB (publ).

Provide Operating Margin
for MedCap AB (publ).

Provide Net Margin
for MedCap AB (publ).

Provide FCF Margin
for MedCap AB (publ).

Show all solvency ratios
for MedCap AB (publ).

Provide D/E Ratio
for MedCap AB (publ).

Provide D/A Ratio
for MedCap AB (publ).

Provide Interest Coverage Ratio
for MedCap AB (publ).

Provide Altman Z-Score Ratio
for MedCap AB (publ).

Provide Quick Ratio
for MedCap AB (publ).

Provide Current Ratio
for MedCap AB (publ).

Provide Cash Ratio
for MedCap AB (publ).

What is the historical Revenue growth
over the last 5 years for MedCap AB (publ)?

What is the historical Net Income growth
over the last 5 years for MedCap AB (publ)?

What is the current Free Cash Flow
of MedCap AB (publ)?

Discuss the annual earnings per share (EPS)
trend over the past five years for MedCap AB (publ).

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
MedCap AB (publ)

Current Assets 873.7m
Cash & Short-Term Investments 287.7m
Receivables 319.1m
Other Current Assets 266.9m
Non-Current Assets 1B
Long-Term Investments 500k
PP&E 382.6m
Intangibles 630.7m
Other Non-Current Assets 6.6m
Current Liabilities 331.9m
Accounts Payable 238.6m
Other Current Liabilities 93.3m
Non-Current Liabilities 369m
Long-Term Debt 296.1m
Other Non-Current Liabilities 72.9m
Efficiency

Earnings Waterfall
MedCap AB (publ)

Revenue
1.8B SEK
Cost of Revenue
-954.9m SEK
Gross Profit
834.2m SEK
Operating Expenses
-539.9m SEK
Operating Income
294.3m SEK
Other Expenses
-66.4m SEK
Net Income
227.9m SEK

Free Cash Flow Analysis
MedCap AB (publ)

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MCAP Profitability Score
Profitability Due Diligence

MedCap AB (publ)'s profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive Free Cash Flow
Positive 3-Year Average ROE
64/100
Profitability
Score

MedCap AB (publ)'s profitability score is 64/100. The higher the profitability score, the more profitable the company is.

MCAP Solvency Score
Solvency Due Diligence

MedCap AB (publ)'s solvency score is 85/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
85/100
Solvency
Score

MedCap AB (publ)'s solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MCAP Price Targets Summary
MedCap AB (publ)

Wall Street analysts forecast MCAP stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MCAP is 545.7 SEK with a low forecast of 540.35 SEK and a high forecast of 561.75 SEK.

Lowest
Price Target
540.35 SEK
9% Downside
Average
Price Target
545.7 SEK
8% Downside
Highest
Price Target
561.75 SEK
5% Downside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MCAP?

Click here to dive deeper.

Dividends

MedCap AB (publ)
does not pay dividends
Shareholder Yield

Current shareholder yield for MCAP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MCAP Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one MCAP stock?

The intrinsic value of one MCAP stock under the Base Case scenario is 486.21 SEK.

Is MCAP stock undervalued or overvalued?

Compared to the current market price of 591 SEK, MedCap AB (publ) is Overvalued by 18%.

Back to Top